Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Basel Ramlawi, MD
Paramount Heart
Principal Investigator - John Forrest, MD
Yale University
Principal Investigator - Michael Reardon, MD
The Methodist Hospital Research Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Abrazo Arizona Heart Hospital
Phoenix, Arizona, United States
- Scripps Memorial Hospital la Jolla
La Jolla, California, United States
- Los Robles Hospital & Medical Center
Thousand Oaks, California, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- Morton Plant Hospital
Clearwater, Florida, United States
- Healthpark Medical Center
Fort Myers, Florida, United States
- Tallahassee Memorial Hospital
Tallahassee, Florida, United States
- Piedmont Atlanta Hospital
Atlanta, Georgia, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Spectrum Health Hospital
Grand Rapids, Michigan, United States
- Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
- North Shore University Hospital
Manhasset, New York, United States
- the Mount Sinai Hospital
New York, New York, United States
- Saint Francis Hospital
Roslyn, New York, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Ohiohealth Riverside Methodist Hospital
Columbus, Ohio, United States
- Oregon Health & Science University Hospital
Portland, Oregon, United States
- Upmc Pinnacle Harrisburg Campus
Harrisburg, Pennsylvania, United States
- Paramount Heart
Villanova, Pennsylvania, United States
- Baylor Jack and Jane Hamilton Heart & Vascular Hospital
Dallas, Texas, United States
- Houston Methodist Hospital
Houston, Texas, United States
- Aurora St. Luke'S Medical Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2018
- Primary completion
- 13 Nov 2019
- Completion
- 31 Dec 2030
- Last update posted
- 5 May 2026
- Registered enrollment
- 150
- Registry id
- NCT03635424
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.